Advanced Proteome Therapeutics Corporation (APTCF) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Burnaby, BC, Canada. The current CEO is Benjamin Krantz.
APTCF has IPO date of 2009-07-10, listed on the Other OTC, a market capitalization of $149.63K.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
